oritavancin Injection [Orbactiv]

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This article was written with the aim to establish a consensus clinical pathway for long-acting lipoglycopeptide antibiotics such… (More)
Is this relevant?
Review
2015
Review
2015
Oritavancin (Orbactiv®) is a new generation lipoglycopeptide approved for use in adult patients with acute bacterial skin and… (More)
  • table 1
  • table 2
Is this relevant?
Review
2014
Review
2014
Oritavancin (Orbactiv®) is a lipoglycopeptide antibacterial drug with activity against Gram-positive bacteria developed by The… (More)
Is this relevant?